Detalhe da pesquisa
1.
Phenotypic effect of GBA1 variants in individuals with and without Parkinson's disease: The RAPSODI study.
Neurobiol Dis
; 188: 106343, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37926171
2.
Interplay between speech and gait variables in Parkinson's disease patients treated with subthalamic nucleus deep brain stimulation: A long-term instrumental assessment.
Eur J Neurol
; 30(7): 1963-1972, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-36971736
3.
Who is at Risk of Parkinson Disease? Refining the Preclinical Phase of GBA1 and LRRK2 Variant Carriers: a Clinical, Biochemical, and Imaging Approach.
Curr Neurol Neurosci Rep
; 23(4): 121-130, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36881256
4.
Glucocerebrosidase-associated Parkinson disease: Pathogenic mechanisms and potential drug treatments.
Neurobiol Dis
; 166: 105663, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35183702
5.
Glucocerebrosidase 1 and leucine-rich repeat kinase 2 in Parkinson disease and interplay between the two genes.
J Neurochem
; 159(5): 826-839, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34618942
6.
Idiopathic brain calcification in a patient with hereditary hemochromatosis.
BMC Neurol
; 20(1): 113, 2020 Mar 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-32228506
7.
Twenty years on: Myoclonus-dystonia and ε-sarcoglycan - neurodevelopment, channel, and signaling dysfunction.
Mov Disord
; 34(11): 1588-1601, 2019 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31449710
8.
LRRK2 Parkinsonism: Does the Response to Gut Bacteria Mitigate the Neurological Picture?
Mov Disord
; 36(1): 71-75, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33107648
9.
Telemedicine in Movement Disorders: Leçons du COVID-19.
Mov Disord
; 35(11): 1893-1896, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32881108
10.
Reply to: "A New Day: The Role of Telemedicine in Reshaping Care for Persons With Movement Disorders".
Mov Disord
; 35(11): 1903-1904, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32940920
11.
The Gut Microbiota in Parkinson Disease: Interactions with Drugs and Potential for Therapeutic Applications.
CNS Drugs
; 38(5): 315-331, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38570412
12.
Targeting the GBA1 pathway to slow Parkinson disease: Insights into clinical aspects, pathogenic mechanisms and new therapeutic avenues.
Pharmacol Ther
; 246: 108419, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37080432
13.
A study on the correlations between acoustic speech variables and bradykinesia in advanced Parkinson's disease.
Front Neurol
; 14: 1213772, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37533469
14.
α-Synuclein expression in response to bacterial ligands and metabolites in gut enteroendocrine cells: an in vitro proof of concept study.
Brain Commun
; 5(6): fcad285, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37953845
15.
Evaluation of an Adapted Semi-Automated DNA Extraction for Human Salivary Shotgun Metagenomics.
Biomolecules
; 13(10)2023 10 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37892187
16.
Long-term effects of subthalamic nucleus deep brain stimulation on speech in Parkinson's disease.
Sci Rep
; 13(1): 11462, 2023 07 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-37454168
17.
Long-term effects of bilateral subthalamic nucleus deep brain stimulation on gait disorders in Parkinson's disease: a clinical-instrumental study.
J Neurol
; 270(9): 4342-4353, 2023 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-37208527
18.
Genetic variations in GBA1 and LRRK2 genes: Biochemical and clinical consequences in Parkinson disease.
Front Neurol
; 13: 971252, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36034282
19.
Freezing of Gait in Parkinson's Disease Patients Treated with Bilateral Subthalamic Nucleus Deep Brain Stimulation: A Long-Term Overview.
Biomedicines
; 10(9)2022 Sep 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-36140318
20.
The gut-brain axis and Parkinson disease: clinical and pathogenetic relevance.
Ann Med
; 53(1): 611-625, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-33860738